Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,810Revenue (TTM) $M280Net Margin (%)-19.3Altman Z-Score3.5
Enterprise Value $M1,693EPS (TTM) $-1.4Operating Margin %-15.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-19.2Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %--Quick Ratio9.2Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %--Current Ratio9.8Lower Leverage y-yN
Price/Free Cash Flow110y-y EBITDA Growth Rate %-318.6ROA % (ttm)-12.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-23.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M40.1ROIC % (ttm)-26.7Gross Margin Increase y-yN

Gurus Latest Trades with PCRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PCRX is held by these investors:



PCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Williams Kristen MarieCAO and General Counsel 2017-05-15Sell21,041$50.86-11.23view
Scibetta James SPresident 2017-05-15Sell20,000$51.2-11.82view
Scibetta James SPresident 2017-01-17Sell20,000$38.5317.18view
STACK DAVID MCEO and Chairman 2017-01-17Sell15,000$38.4117.55view
STACK DAVID MCEO and Chairman 2016-11-15Sell15,000$37.2821.11view
Scibetta James SPresident 2016-11-15Sell20,000$36.523.7view
STACK DAVID MCEO and Chairman 2016-08-15Sell15,000$45.32-0.38view
Scibetta James SPresident 2016-08-15Sell25,000$45.21-0.13view
Riker Lauren BullaroVice President, Finance 2016-06-07Sell938$47.66-5.27view
Williams Kristen MarieCAO and General Counsel 2016-06-06Sell600$47.2-4.34view

Press Releases about PCRX :

Quarterly/Annual Reports about PCRX:

News about PCRX:

Articles On GuruFocus.com
Pacira Pharmaceuticals Announces Resignation of James Scibetta May 23 2017 
Paul Tudor Jones’ Top 4 Health Care Buys May 18 2017 
Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference May 10 2017 
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to Trea May 03 2017 
Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and Confere Apr 27 2017 
MonoSol Rx Appoints James S. Scibetta to Board of Directors Apr 11 2017 
Pacira Pharmaceuticals, Inc. to Present at the Needham Healthcare Conference Apr 03 2017 
4 Biotech Stocks to Watch Mar 22 2017 
Trinity Health and Pacira Pharmaceuticals Announce Collaboration to Decrease Opioid Use Nationwide Mar 16 2017 
Phase 4 Study Shows EXPAREL® Versus an Active Comparator Significantly Reduces Opioid Consumption Mar 14 2017 

More From Other Websites
Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got May 26 2017
Pacira Pharmaceuticals Announces Resignation of James Scibetta May 23 2017
ETFs with exposure to Pacira Pharmaceuticals, Inc. : May 22, 2017 May 22 2017
Pacira Pharmaceuticals, Inc. :PCRX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017 May 19 2017
Paul Tudor Jones' Top 4 Health Care Buys May 18 2017
Edited Transcript of PCRX earnings conference call or presentation 4-May-17 12:30pm GMT May 10 2017
Pacira Pharmaceuticals to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference May 10 2017
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US : May... May 08 2017
Pacira reports 1Q loss May 04 2017
Pacira Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results May 04 2017
Investor Network: Pacira Pharmaceuticals, Inc. to Host Earnings Call May 04 2017
New Research Shows Vast Majority of Oral Surgery Patients Would Choose Non-opioid Medication to... May 03 2017
Pacira Pharmaceuticals Announces Timing for First Quarter 2017 Financial Results Webcast and... Apr 27 2017
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : PCRX-US :... Apr 25 2017
Can Pacira Pharmaceuticals' Exparel Reduce Opioid Abuse? Apr 19 2017
Can Drugmakers Cure the Opioid Crisis? Apr 18 2017
Pacira Pharmaceuticals, Inc. – Value Analysis (NASDAQ:PCRX) : April 17, 2017 Apr 17 2017
Pacira Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : PCRX-US :... Apr 13 2017
Pacira Focuses on Lead Candidate Exparel's Label Expansion Apr 12 2017
MonoSol Rx Appoints James S. Scibetta to Board of Directors Apr 11 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)